Please use this identifier to cite or link to this item: https://doi.org/10.1097/MD.0000000000020336
DC FieldValue
dc.titleManagement of locally advanced synchronous colorectal and prostate cancers: A case report
dc.contributor.authorTey, Y.Q.
dc.contributor.authorRavi, K.
dc.contributor.authorChong, C.S.
dc.contributor.authorChiong, E.
dc.contributor.authorHo, J.
dc.contributor.authorTey, J.C.S.
dc.contributor.authorHo, F.
dc.date.accessioned2021-08-10T10:02:18Z
dc.date.available2021-08-10T10:02:18Z
dc.date.issued2020
dc.identifier.citationTey, Y.Q., Ravi, K., Chong, C.S., Chiong, E., Ho, J., Tey, J.C.S., Ho, F. (2020). Management of locally advanced synchronous colorectal and prostate cancers: A case report. Medicine 99 (22) : e20336. ScholarBank@NUS Repository. https://doi.org/10.1097/MD.0000000000020336
dc.identifier.issn15365964
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/196452
dc.description.abstractINTRODUCTION: Synchronous colorectal and prostate malignancies are uncommon, with standard treatment guidelines not yet established. Chemoradiation therapy is involved in both colorectal and prostate cancers. However, differing dosage regimens and effects of irradiation field on anatomical planes for surgery makes management of the synchronous cancers challenging. We report the first case of synchronous prostate and rectal cancer being treated with a combination of treatment modalities with a unique addition of high dose rate prostate brachytherapy boost. PATIENT CONCERNS: The patient, a 69-year-old Chinese gentleman, presented with per-rectal bleeding with alternating bowel habits and a hemoglobin drop. He also had a history of urinary urge incontinence. DIAGNOSIS: Following diagnostic workup, he was diagnosed with synchronous rectal adenocarcinoma (T3N1M0) and prostate malignancy (T2bN0M0). INTERVENTIONS: The management consisted of neoadjuvant androgen deprivation therapy (ADT) and pelvic chemoradiation, followed by high dose rate prostate brachytherapy boost and subsequently anterior resection. OUTCOMES: Following therapy, the patient has no evidence of local recurrence or distant metastasis. CONCLUSION: We suggest a new feasible treatment strategy for the management of synchronous colorectal and prostate cancers.
dc.publisherNLM (Medline)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScopus OA2020
dc.typeArticle
dc.contributor.departmentSURGERY
dc.contributor.departmentMEDICINE
dc.description.doi10.1097/MD.0000000000020336
dc.description.sourcetitleMedicine
dc.description.volume99
dc.description.issue22
dc.description.pagee20336
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1097_MD_0000000000020336.pdf1.16 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons